Physician

Sridhar Beeram, MD

According to 2025 Medicare claims, Sridhar Beeram, MD (NPI: 1275626970) practices hematology/oncology in the San Antonio-New Braunfels, TX market, with the plurality of this provider's patient population coming from Bexar, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1811944101; TIN: 752131429) and primary practice location at 78240-5251. Beeram is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645) and Prime Accountable Care East LLC (ACO ID: D0343), participating under both the MSSP and REACH models.

Beeram's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 809 traditional Medicare patients, billed 236,785 HCPCS/CPT codes, and received $4,886,532 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,565 prescription claims across 286 beneficiaries totaling $7,537,519 in drug costs, led by Cabometyx (Cabozantinib S-Malate). 2022 DME data shows 29 claims. Open Payments data shows 32 records totaling $1,797. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $2,019,683 to $4,886,532. Similarly, Part D prescription costs have moved sharply higher in recent years, from $1,216,603 to $7,537,519. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	586	185,029	$2,019,683
2016	722	133,237	$1,824,461
2017	680	128,092	$1,787,688
2018	692	134,400	$2,073,037
2019	671	152,485	$2,527,795
2020	684	176,324	$3,108,551
2021	722	225,478	$3,859,633
2022	760	271,309	$4,746,521
2023	784	229,065	$4,657,207
2024	809	236,785	$4,886,532

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	195	892	$1,216,603
2016	156	703	$1,542,737
2017	152	681	$2,627,357
2018	190	771	$3,060,361
2019	208	938	$3,567,368
2020	225	1,088	$4,596,140
2021	234	1,302	$6,314,812
2022	243	1,392	$7,235,603
2023	245	1,390	$6,263,049
2024	286	1,565	$7,537,519

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	88	$32,889
2016	N/R	48	$4,735
2017	N/R	63	$12,659
2018	N/R	33	$5,290
2019	N/R	12	$2,765
2020	N/R	24	$2,100
2021	N/R	N/R	N/R
2022	N/R	29	$1,172
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	421	1,371	$89
80053	Blood test, comprehensive group of blood chemicals	460	1,585	$10
36415	Insertion of needle into vein for collection of blood sample	445	1,600	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	450	1,544	$8
83615	Lactate dehydrogenase (enzyme) level	444	1,419	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Cabometyx	Cabozantinib S-Malate	41	1,230	$1,083,013
Promacta	Eltrombopag Olamine	45	1,530	$819,710
Jakafi	Ruxolitinib Phosphate	68	2,028	$692,355
Brukinsa	Zanubrutinib	39	1,170	$584,836
Revlimid	Lenalidomide	37	910	$574,957

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	32	$1,797	Bayer Healthcare Pharmaceuticals Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sridhar Beeram, MD?

Tedicare shows public-source Medicare data for Sridhar Beeram, MD (NPI 1275626970), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sridhar Beeram, MD have ACO affiliation data?

Sridhar Beeram, MD is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645) and Prime Accountable Care East LLC (REACH, ACO ID D0343).

What billing organization is linked to Sridhar Beeram, MD?

Sridhar Beeram, MD is linked to TEXAS ONCOLOGY PA (billing NPI 1811944101) in the available physician profile data.

Does Sridhar Beeram, MD have Open Payments data?

Sridhar Beeram, MD has 32 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.